StockData
BrainStorm Cell Therapeutics Inc. logo

BrainStorm Cell Therapeutics Inc. (BCLI) dividend history

BCLIOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$0.77−0.01 (-1.17%)

Close on Oct 19, 2026Market cap $8.50MP/E –Yield –

Dividends

BrainStorm Cell Therapeutics has not reported a dividend

No dividend per share appears in BrainStorm Cell Therapeutics's annual filings since fiscal 2010.

See a number that looks wrong?